Delivery Order SPE2DB20D3104-SPE2DB23FV8W5
Award Date 9/6/23
Potential Completion Date 9/7/23
Potential Value $1.2K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of 4,562,139,657 units of Naloxone HCl 4 mg Nasal Spray, a critical medication used for the treatment of opioid overdose. The contract has a ceiling value of $1,199.86 and a completion date of September 13, 2023. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award, valued at $2,782.09, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,561,182,545 units of Naloxone HCL 4 mg Nasal Spray, a critical medication used to treat opioid overdoses. This is a firm fixed-price delivery order with a completion date of June 9, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a...
- This federal contract award, valued at $14,421.35, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Naloxone Hydrochloride 4 mg Nasal Spray, a critical medication used to reverse opioid overdoses. This is a delivery order contract with a firm fixed price type and an ultimate completion date of May 15, 2023. The contract does not have a set-aside designation, indicating open competition....
- This federal contract award, valued at $3,010.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,563,043,264 units of NALOXONE HCL 4 MG NASAL SPRAY 2S, a critical medication used to treat opioid overdose. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999 and running through...
- This federal contract award, valued at $2,321.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,561,244,594 units of Naloxone HCl 4 mg Nasal Spray, a critical medication used for the emergency treatment of opioid overdose. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- This federal contract award, valued at $7,194.83, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4,557,108,798 units of 4 mg Naloxone HCL nasal spray, a medication used to treat opioid overdose. The contract has a completion date of May 5, 2022 and utilizes a firm fixed price pricing type. Amerisourcebergen Drug Corp is a subsidiary of the parent company...
- This federal contract award, valued at $12,960.05, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of 4,562,251,316 units of 4 mg Naloxone HCL nasal spray, a critical medication used to reverse opioid overdoses. This is a firm fixed-price delivery order contract with a completion date of September 21, 2023. The contract was awarded on an open competition basis,...
- This federal contract award, valued at $4,707.45, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,560,941,949 units of Naloxone HCL 4 mg Nasal Spray, a critical medication used to reverse opioid overdoses. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,560,983,291 units of Naloxone HCL 4 mg Nasal Spray. The delivery order, valued at $1,845.84, has a firm fixed-price and is expected to be completed by May 19, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is for the provision of 4,561,027,452 units of Naloxone HCL 4 mg Nasal Spray, a critical medication used to treat opioid overdoses. The award, valued at $2,931.70, has a firm fixed-price structure and an ultimate completion date of May 24, 2023. This contract is not set aside for any specific business type....